Dr. Anton Grasch, MD
Claim this profileCentral Washington Health Services Association d/b/a Confluence Health
Studies Colorectal Cancer
Studies Type 2 Diabetes
9 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Anton Grasch, MD is currently running
Vaccine
for Respiratory Syncytial Virus
The aim of this study is to demonstrate the immune response and to evaluate safety of the RSVPreF3 OA investigational vaccine in non-immunocompromised adults 18-49 years of age (YOA), who are at increased risk (AIR) for respiratory syncytial virus (RSV) disease, compared to older adults (OA) (>=) 60 YOA and above
Recruiting2 awards Phase 33 criteria
Inclisiran
for Cardiovascular Disease
This trial is testing inclisiran, an injectable drug, on people with heart disease who are already on strong cholesterol-lowering medications. The goal is to see if inclisiran can further reduce the risk of heart attacks and strokes by lowering bad cholesterol levels. Participants will receive the injection periodically. Inclisiran works by significantly reducing bad cholesterol levels.
Recruiting1 award Phase 33 criteria
More about Anton Grasch, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Anton Grasch, MD has experience with
- Tirzepatide
- RSVPreF3 OA Investigational Vaccine
- Placebo
- Blood Sample Collection
- Mt-sDNA 2.0 Screening Test
- Dulaglutide
Breakdown of trials Anton Grasch, MD has run
Colorectal Cancer
- Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
- Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
Type 2 Diabetes
Diabetes
Respiratory Syncytial Virus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anton Grasch, MD specialize in?
Anton Grasch, MD focuses on Colorectal Cancer and Type 2 Diabetes. In particular, much of their work with Colorectal Cancer has involved treating patients, or patients who are undergoing treatment.
Is Anton Grasch, MD currently recruiting for clinical trials?
Yes, Anton Grasch, MD is currently recruiting for 5 clinical trials in Wenatchee Washington. If you're interested in participating, you should apply.
Are there any treatments that Anton Grasch, MD has studied deeply?
Yes, Anton Grasch, MD has studied treatments such as Tirzepatide, RSVPreF3 OA investigational vaccine, Placebo.
What is the best way to schedule an appointment with Anton Grasch, MD?
Apply for one of the trials that Anton Grasch, MD is conducting.
What is the office address of Anton Grasch, MD?
The office of Anton Grasch, MD is located at: Central Washington Health Services Association d/b/a Confluence Health, Wenatchee, Washington 98801 United States. This is the address for their practice at the Central Washington Health Services Association d/b/a Confluence Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.